The primary mission of Stago Group Research & Development (R&D) division is to develop products and solutions (automatic analysers, reagents, consumables, services, etc.) that meet the needs of biomedical scientists and clinicians, with the goal of improving treatment for haemostasis and thrombosis. Working alongside the scientific community, R&D also focuses on identifying and studying new markers and methods for exploration in these areas.
Since 1962, Stago Group has concentrated its attention on biomedical science, specialising in the "emerging" sector of Haemostasis. Thanks to this clear focus, the group is now recognized worldwide by the scientific community in this field.
Stago continues to maintain and develop strong links with the Haemostasis community on a day-to-day basis by: